lncRNA MAFG-AS1 enhances radioresistance of glioblastoma cells via miR-642a-5p/Notch1 axis

被引:6
|
作者
Zhang, Xi [1 ]
Li, Rui [2 ]
机构
[1] Yaan Peoples Hosp, Dept Oncol, Yaan, Peoples R China
[2] Wenjiang Dist Peoples Hosp, Dept Neurosurg, Chengdu, Peoples R China
关键词
lncRNA MAFG-AS1; miR-642a-5p; Notch1; glioblastoma; radioresistance; CANCER; PROLIFERATION; SUPPRESSION; MECHANISMS; INDUCTION;
D O I
10.55782/ane-2022-030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study was designed to explore the function of lncRNA MAFG-AS1/miR-642a-5p/Notch1 in glioblastoma (GBM) cells under radiation. GBM cells (M059K and M059J) were transfected or/and irradiated. Western blotting was used to detect Notch1 protein and its downstream Hes1 protein. Cell Counting Kit-8 assay and flow cytometry were applied for viability and apoptosis tests, respectively. Luciferase reporter plasmids and Ago2 antibody were used to verify the predicted binding of miR-642a-5p to MAFG-AS1 or Notch1 mRNA. Notch1 and MAFG-AS1 were highly expressed and miR-642a-5p was lowly expressed in radioresistant M059K cells. Knockdown of Notch1 inhibited radioresistance and promoted apoptosis in M059K cells. MAFG-AS1 competed with Notch1 mRNA for binding of miR-642a-5p and therefore promoted the expression of Notch1. Overexpression of miR-642a-5p or silencing of MAFG-AS1 inhibited the radioresistance of M059K cells. Knockdown of Notch1 or overexpression of miR-642a-5p reduced viability and increased apoptosis in irradiated M059J cells overexpressing MAFG-AS1. MAFG-AS1 reduces the radiosensitivity of GBM cells via miR-642a-5p/Notch1 axis.
引用
收藏
页码:315 / 326
页数:12
相关论文
共 50 条
  • [1] LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis
    Sui, Yuan
    Lin, Guangyao
    Zheng, Yinshi
    Huang, Wenqi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 859
  • [2] LncRNA MAFG-AS1 affects the tumorigenesis of breast cancer cells via the miR-574-5p/SOD2 axis
    Dai, Ji
    Zhang, Shuangshuang
    Sun, Haohang
    Wu, Yulian
    Yan, Meidi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 560 : 119 - 125
  • [3] LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis
    Liu, Yuanlin
    Liu, Yan
    Wang, Yan
    Wang, Qiang
    Yan, Yan
    Zhang, Dandan
    Liu, Huiqin
    ONCOLOGY RESEARCH, 2024, 32 (07) : 1221 - 1229
  • [4] LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation
    Zhao, Hao
    Li, Jun
    Yan, Xin
    Bian, Xinchao
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3493 - 3501
  • [5] LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells
    Chenye Tang
    Yuntao Wu
    Xiao Wang
    Kean Chen
    Zhiling Tang
    Xiao Guo
    Human Cell, 2021, 34 : 588 - 597
  • [6] LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells
    Tang, Chenye
    Wu, Yuntao
    Wang, Xiao
    Chen, Kean
    Tang, Zhiling
    Guo, Xiao
    HUMAN CELL, 2021, 34 (02) : 588 - 597
  • [7] Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p/LGMN axis
    Liu, Yuanlin
    Wang, Ye
    Shen, Xiang
    Chen, Chen
    Ni, Huihua
    Sheng, Nan
    Hua, Minhui
    Wu, Yanling
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 117
  • [8] Regulatory effect of the MAFG-AS1/miR-150-5p/MYB axis on the proliferation and migration of breast cancer cells
    Jia, Hongyao
    Wu, Di
    Zhang, Zhiru
    Li, Sijie
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (01) : 33 - 44
  • [9] Atomoxetine suppresses radioresistance in glioblastoma via circATIC/miR-520d-5p/Notch2-Hey1 axis
    Seok, Hyun Jeong
    Choi, Jae Yeon
    Lee, Dong Hyeon
    Shin, Incheol
    Bae, In Hwa
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [10] MACC1 Correlates with Tumor Progression and Immune Cell Infiltration of Colon Adenocarcinoma and is Regulated by the lncRNA ZFAS1/miR-642a-5p Axis
    Liu, Bi-Xia
    Yang, Jing
    Zeng, Chunyan
    Chen, Youxiang
    JOURNAL OF ONCOLOGY, 2022, 2022